Cell viability was detected by MTT assay. H9c2 cells plated in 96-well plates at 3×104 cells/well were pre-treated with cyanidin for 3 h and co-treated with cisplatin for 24 h, and then cells were incubated with different treatments and different times. After incubation, the medium was removed and 10 µl MTT (5 mg/ml) (Sigma-Aldrich, Saint Louis, Missouri, USA) was added for 4 h. After the incubation, 150 µl DMSO was added to dissolve formazan crystals, and the absorbance was measured at 570 nm with a microplate reader Elx800 (Bio-Tek, Winooski, Vermont, USA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.